Charles River offers an integrated approach to ophthalmology research. Compounds or implantable devices intended for ocular treatment can be assessed for efficacy, safety and toxicity in multiple species. Ocular effects of compounds administered by other routes, such as oral, can also be characterized. These studies can be conducted under GLP conditions either as stand-alone studies or as part of general and specialty toxicology programs. Non-GLP pilot or proof-of-concept studies are also available for your early research needs.